Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-23-020926
Filing Date
2023-04-27
Accepted
2023-04-27 16:08:50
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A ny20007748x2_defa14a.htm DEFA14A 17007
2 ny20007748x2_nc1.jpg GRAPHIC 363084
3 ny20007748x2_nc2.jpg GRAPHIC 402367
  Complete submission text file 0001140361-23-020926.txt   1072219
Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Filer) CIK: 0001806952 (see all company filings)

EIN.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40502 | Film No.: 23856875
SIC: 2834 Pharmaceutical Preparations